- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01897298
Urban Training for COPD Patients
April 26, 2018 updated by: Judith Garcia-Aymerich
Effectiveness of an Intervention of Urban Training in Patients With Chronic Obstructive Pulmonary Disease (COPD): a Randomised Controlled Trial
This project plans on a training intervention by using public spaces and urban walkable trails, adapted to each patient needs and capabilities.
Primary objective is to assess 12 months effectiveness of the intervention with respect to: (primary outcome): physical activity level, and (secondary outcomes): COPD admissions, exercise capacity, body composition, quality of life, and mental health.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
412
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Barcelona, Spain, 08003
- Hospital del Mar
-
Barcelona, Spain, 08036
- Hospital Clínic
-
-
Barcelona
-
Badalona, Barcelona, Spain, 08916
- Hospital Germans Trias i Pujol
-
Mataró, Barcelona, Spain, 08303
- CAP Maresme
-
Viladecans, Barcelona, Spain, 08840
- CAP Maria Bernades
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 130 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age > 45 years
- COPD diagnosed by pulmonary function tests during clinical stability, with a ratio of forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) ≤ 0.70
- clinical stability, defined as at least 4 weeks without antibiotics or oral corticosteroids.
Exclusion Criteria:
- living >6 months/year outside of the included municipalities,
- living to a distance higher than 500 meters to any of the urban trails used for the study,
- mental disability according to the Mini Mental State Examination in its validated Spanish version
- comorbidity that could interfere with study tests (e.g., lower limb amputation)
- severe psychiatric disease or severe comorbidity limiting survival at one year, according to medical history.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Urban training Intervention
Patients will be advised to walk in the defined urban trails.
|
Recommendation to walk a minimum of 5 days per week in urban walkable trails appropriate for the patient.
|
No Intervention: Usual care
Patients will continue their usual care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in physical activity
Time Frame: Baseline and 12 months follow-up
|
Change in physical activity between baseline and 12 months follow-up, as defined by average steps per day measured with an activity monitor
|
Baseline and 12 months follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
COPD admissions to emergency-room or hospital
Time Frame: 12 months follow-up
|
12 months follow-up
|
|
Change in exercise capacity, as measured with 6-min walking distance
Time Frame: Baseline and 12 months
|
Change in exercise capacity between baseline and 12 months, as measured with 6-min walking distance
|
Baseline and 12 months
|
Change in body weight and composition
Time Frame: Baseline and 12 month
|
Change in body weight and composition between baseline and 12m follow-up, as measured with bioimpedance
|
Baseline and 12 month
|
Change in quality of life
Time Frame: Baseline and 12-m
|
Change in quality of life between baseline and 12-m follow-up, as measured with CAT and CCQ
|
Baseline and 12-m
|
Change in anxiety and depression symptoms
Time Frame: Baseline and 12 months
|
Change in anxiety and depression symptoms between baseline and 12 months follw-up, as measured with the HAD scale
|
Baseline and 12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in cognitive status
Time Frame: Baseline and 12months
|
Changes between baseline and 12 months follow-up in cognitive status measured with the Phototest
|
Baseline and 12months
|
Changes in the Clinical PPAC
Time Frame: Baseline and 12months
|
Changes between baseline and 12 months follow-up in phsyical activity measured with the Clinical visit "PROactive Physical Activity in COPD" instrument
|
Baseline and 12months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Judith Garcia-Aymerich, MD PhD, Centre for Research in Environmental Epidemiology (CREAL)
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Delgado-Ortiz L, Arbillaga-Etxarri A, Rodriguez-Chiaradia DA, Gimeno-Santos E, Barberan-Garcia A, Balcells E, Rodriguez-Roisin R, Garcia-Aymerich J. Physical activity and cardiac autonomic dysfunction in patients with chronic obstructive pulmonary disease: A cross-sectional analysis. Ann Phys Rehabil Med. 2022 May;65(3):101501. doi: 10.1016/j.rehab.2021.101501. Epub 2021 Nov 22.
- Koreny M, Demeyer H, Arbillaga-Etxarri A, Gimeno-Santos E, Barberan-Garcia A, Benet M, Balcells E, Borrell E, Marin A, Rodriguez Chiaradia DA, Vall-Casas P, Vilaro J, Rodriguez-Roisin R, Garcia-Aymerich J. Determinants of study completion and response to a 12-month behavioral physical activity intervention in chronic obstructive pulmonary disease: A cohort study. PLoS One. 2019 May 20;14(5):e0217157. doi: 10.1371/journal.pone.0217157. eCollection 2019.
- Arbillaga-Etxarri A, Gimeno-Santos E, Barberan-Garcia A, Balcells E, Benet M, Borrell E, Celorrio N, Delgado A, Jane C, Marin A, Martin-Cantera C, Monteagudo M, Montella N, Munoz L, Ortega P, Rodriguez DA, Rodriguez-Roisin R, Simonet P, Toran-Monserrat P, Torrent-Pallicer J, Vall-Casas P, Vilaro J, Garcia-Aymerich J. Long-term efficacy and effectiveness of a behavioural and community-based exercise intervention (Urban Training) to increase physical activity in patients with COPD: a randomised controlled trial. Eur Respir J. 2018 Oct 18;52(4):1800063. doi: 10.1183/13993003.00063-2018. Print 2018 Oct.
- Arbillaga-Etxarri A, Gimeno-Santos E, Barberan-Garcia A, Benet M, Borrell E, Dadvand P, Foraster M, Marin A, Monteagudo M, Rodriguez-Roisin R, Vall-Casas P, Vilaro J, Garcia-Aymerich J; Urban Training Study Group. Socio-environmental correlates of physical activity in patients with chronic obstructive pulmonary disease (COPD). Thorax. 2017 Sep;72(9):796-802. doi: 10.1136/thoraxjnl-2016-209209. Epub 2017 Mar 1.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2013
Primary Completion (Actual)
February 1, 2016
Study Completion (Actual)
March 1, 2016
Study Registration Dates
First Submitted
July 3, 2013
First Submitted That Met QC Criteria
July 9, 2013
First Posted (Estimate)
July 11, 2013
Study Record Updates
Last Update Posted (Actual)
April 27, 2018
Last Update Submitted That Met QC Criteria
April 26, 2018
Last Verified
April 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PI11/01283
- 147/2011 (Other Grant/Funding Number: SEPAR)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease (COPD)
-
University College, LondonUniversity of Cambridge; National Institute for Health Research, United Kingdom and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Virginia Commonwealth UniversityFisher and Paykel HealthcareCompletedChronic Obstructive Pulmonary Disease(COPD)United States
-
Reham Mohammed ElmorshedyCompletedChronic Obstructive Pulmonary Disease(COPD)Egypt
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Medtronic BRCUnknownCOPD | COPD Exacerbation
-
Beaumont HospitalAerogenCompletedChronic Obstructive Pulmonary Disease | COPD | COPD Exacerbation | Copd Exacerbation AcuteIreland
-
Chiesi Farmaceutici S.p.A.CompletedModerate to Severe Chronic Obstructive Pulmonary Disease (COPD)Bulgaria, Germany, Hungary, Poland, Russian Federation, United Kingdom
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary Disease (COPD) | COPDUnited Kingdom
-
Elpen Pharmaceutical Co. Inc.Completed
-
Rigshospitalet, DenmarkUnknown
Clinical Trials on Urban training
-
Universidad Complutense de MadridSociedad Española de Neumología y Cirugía Torácica; Gerencia de Atención Primaria...RecruitingRespiratory Tract Diseases | Lung Diseases, Obstructive | Chronic Obstructive Pulmonary DiseaseSpain
-
Hospital Clinic of BarcelonaRecruiting
-
University of WashingtonVA Puget Sound Health Care System; Recreational Equipment, Inc. (REI)Completed
-
University of ManitobaUnity Health Toronto; University of Toronto; Ontario Agency for Health Protection...UnknownCardiovascular Diseases | Diabetes Mellitus | Cardiovascular Risk FactorCanada
-
ETH ZurichRecruitingStress | Virtual Reality | Attention | Gait AnalysisSwitzerland
-
National University of SingaporeNational Medical Research Council (NMRC), SingaporeRecruitingStress, PsychologicalSingapore
-
University of ManchesterCompletedPhysical Activity and WellbeingUnited Kingdom
-
Indiana UniversityAmerican Heart AssociationCompletedHeart Failure | Cognitive DysfunctionUnited States
-
Virginia Commonwealth UniversityWithdrawnAttention Fatigue, Attention Restoration
-
Ohio State UniversityCompletedChronic Disease | Pulmonary HypertensionUnited States